Principal component analysis

M Greenacre, PJF Groenen, T Hastie… - Nature Reviews …, 2022 - nature.com
Principal component analysis is a versatile statistical method for reducing a cases-by-
variables data table to its essential features, called principal components. Principal …

[HTML][HTML] The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

ZM Younossi, P Golabi, JM Paik, A Henry… - Hepatology, 2023 - journals.lww.com
Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology Communications
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue …

[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD

VWS Wong, M Ekstedt, GLH Wong, H Hagström - Journal of hepatology, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Current status and future trends of the global burden of MASLD

L Miao, G Targher, CD Byrne, YY Cao… - Trends in Endocrinology & …, 2024 - cell.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most
common chronic liver disease globally, affecting more than a third of the world's adult …

The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

LA Díaz, JP Arab, A Louvet, R Bataller… - Nature Reviews …, 2023 - nature.com
Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

the epidemiologic burden of non‐alcoholic fatty liver disease across the world

L Henry, J Paik, ZM Younossi - Alimentary pharmacology & …, 2022 - Wiley Online Library
Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …

Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties

AM Allen, JV Lazarus, ZM Younossi - Journal of hepatology, 2023 - Elsevier
Left unaddressed, non-alcoholic fatty liver disease (NAFLD) will continue to have substantial
health, economic and social implications. To address the challenge, a paradigm shift is …

Steatotic liver disease: pathophysiology and emerging pharmacotherapies

M Kokkorakis, E Muzurović, Š Volčanšek… - Pharmacological …, 2024 - Elsevier
Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis …

P Danpanichkul, K Suparan, P Dutta, C Kaeosri… - Metabolism, 2024 - Elsevier
Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) and
cardiometabolic conditions affect populations across economic strata. Nevertheless, there …

Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice

M Chen, JY Zhu, WJ Mu, HY Luo, Y Li, S Li… - Nature …, 2023 - nature.com
Exercise is an effective non-pharmacological strategy for ameliorating nonalcoholic fatty
liver disease (NAFLD), but the underlying mechanism needs further investigation. Cysteine …